Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andriy Marusyk

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Nature Biotechnology|July 4, 2024
Evolutionary gambit to defeat drug resistance in cancerAndriy Marusyk
Biochimica Et Biophysica Acta|November 6, 2007
Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutationsAndriy Marusyk, James DeGregori
Nature|April 4, 2014
Cancer: Clonal cooperationKornelia Polyak, Andriy Marusyk
Cell Division|October 20, 2006
Building a better model of cancerAndriy Marusyk, James DeGregori
Biochimica Et Biophysica Acta|November 26, 2009
Tumor heterogeneity: causes and consequencesAndriy Marusyk, Kornelia Polyak
Cell Cycle (Georgetown, Tex.)|September 6, 2007
Replicational stress selects for p53 mutationAndriy Marusyk, James DeGregori
Science (New York, N.Y.)|February 2, 2013
Cancer. Cancer cell phenotypes, in fifty shades of greyAndriy Marusyk, Kornelia Polyak
Biochimica Et Biophysica Acta. Reviews on Cancer|February 6, 2017
Somatic clonal evolution: A selection-centric perspectiveJacob Scott, Andriy Marusyk
Cancer Cell|April 15, 2020
Intratumor Heterogeneity: The Rosetta Stone of Therapy ResistanceAndriy Marusyk, Michalina Janiszewska, Kornelia Polyak
Iscience|December 28, 2020
Selection-driven tumor evolution with public goods leads to patterns of clonal expansion consistent with neutral growthJack Edwards, Andriy Marusyk, David Basanta
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Nature Biotechnology|July 4, 2024
Evolutionary gambit to defeat drug resistance in cancerAndriy Marusyk
Biochimica Et Biophysica Acta|November 6, 2007
Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutationsAndriy Marusyk, James DeGregori
Nature|April 4, 2014
Cancer: Clonal cooperationKornelia Polyak, Andriy Marusyk
Cell Division|October 20, 2006
Building a better model of cancerAndriy Marusyk, James DeGregori
Biochimica Et Biophysica Acta|November 26, 2009
Tumor heterogeneity: causes and consequencesAndriy Marusyk, Kornelia Polyak
Cell Cycle (Georgetown, Tex.)|September 6, 2007
Replicational stress selects for p53 mutationAndriy Marusyk, James DeGregori
Science (New York, N.Y.)|February 2, 2013
Cancer. Cancer cell phenotypes, in fifty shades of greyAndriy Marusyk, Kornelia Polyak
Biochimica Et Biophysica Acta. Reviews on Cancer|February 6, 2017
Somatic clonal evolution: A selection-centric perspectiveJacob Scott, Andriy Marusyk
Cancer Cell|April 15, 2020
Intratumor Heterogeneity: The Rosetta Stone of Therapy ResistanceAndriy Marusyk, Michalina Janiszewska, Kornelia Polyak
Iscience|December 28, 2020
Selection-driven tumor evolution with public goods leads to patterns of clonal expansion consistent with neutral growthJack Edwards, Andriy Marusyk, David Basanta
Pageof 8